Category:
Biopharma Research and Development
CAS NO:
N/A
Standard:
ChP,USP,EP,
40 IND Approved
17 US-FDA IND approvals
200+ Stable cell lines: mAbs, bsAbs,ADC, trispecific, TCR, and fusion proteins mAb titres to 12 g/L
Multispecific titres to 7.5 g/L
207 days from gene to US-FDA IND13,000L cell culture capacity 20 million aseptic units per year